the clinical outcome of HMG and MPA used for ovarian stimulation in normalovulatory women

Status

Active, not recruiting

Phases

Phase 3

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONRC-14004419

Enrollment

Unknown

Registered

2014-03-25

Start date

2014-03-25

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

experiment group:HMG and MPA

control:short protocol

Eligibility

Sex/Gender

Female

Age

25 Years to 40 Years

Inclusion criteria

Inclusion criteria: infertility women, aged 25-40 years, normal mentrual cycle (23-35days), tubal or male factors, basal FSH <10IU/l, antral follicle counts more than 5.

Exclusion criteria

Exclusion criteria: PCOS, endometrosis grade 3 or higher, documented ovarian failure,and any contraindications to ovarian stimulation treatment.

Design outcomes

Primary

Measure	Time frame
number of oocyte retrieval;	—

Secondary

Measure	Time frame
number of mature oocytes;number of fertilized oocytes;number of viable embryos;clinical pregnancy rate;	—

Countries

China

Contacts

Public ContactYanping Kuang

Shanghai Ninth People's Hospital

kuangyanp@126.com+86 021-53078108

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 17, 2026